Joseph M. Manko Jr., Director at MYOMO, INC. (MYO), bought 201,197 shares at $0.86 ($174K) on 2026-05-14, disclosed to the SEC on 2026-05-18.
Director Joseph M. Manko Jr. purchased 170,830 shares at $0.86, marking the largest insider purchase in the company's history. This significant buyback signals confidence in the stock's recovery potential following a steep 76% year-to-date decline.
MYO is currently trading at $0.8327, up 0.56% over the last five days despite a 76.68% year-to-date decline. The stock sits 75.86% below its 52-week high of $3.45 and 37.64% above its 52-week low of $0.605.
Upcoming catalysts include the Q1 2026 earnings report on May 7, 2026, which delivered a +21.74% earnings surprise and +8.75% revenue surprise. Additionally, Elevance Health expanded network participation agreements with Myomo on March 12, 2026, adding coverage for tens of millions of members.
The stock faces elevated risk with a short interest of 10.66% and a negative forward P/E of -4.07. Additionally, recent earnings highlights noted increased operating losses and rising expenses despite record revenue.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.86 | 170,830 | $147K | 84.5% |
| 2 | $0.89 | 30,367 | $27K | 15.5% |
| Total | $0.86 avg | 201,197 | $174K | 100% |
| Filing → |
| KRMD | BUY | 2023-12-15 | $700K | — | Filing → |
| KRMD | BUY | 2022-05-16 | $83K | — | Filing → |
| KRMD | BUY | 2020-09-04 | $182K | — | Filing → |